APM

Avidity Partners Management Portfolio holdings

AUM $499M
This Quarter Return
+23.63%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$4.28B
AUM Growth
+$4.28B
Cap. Flow
-$594M
Cap. Flow %
-13.88%
Top 10 Hldgs %
42.06%
Holding
115
New
18
Increased
32
Reduced
19
Closed
30

Top Buys

1
MDGL icon
Madrigal Pharmaceuticals
MDGL
$125M
2
UHS icon
Universal Health Services
UHS
$116M
3
SGRY icon
Surgery Partners
SGRY
$79.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$65.2M
5
PRTA icon
Prothena Corp
PRTA
$59.4M

Top Sells

1
LLY icon
Eli Lilly
LLY
$289M
2
BIIB icon
Biogen
BIIB
$160M
3
XBI icon
SPDR S&P Biotech ETF
XBI
$117M
4
HUM icon
Humana
HUM
$103M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
$98.4M

Sector Composition

1 Healthcare 99.55%
2 Financials 0.45%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CYTK icon
51
Cytokinetics
CYTK
$5.79B
$19.3M 0.42%
420,700
+85,700
+26% +$3.93M
DCPH
52
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$18.5M 0.4%
1,126,000
-65,800
-6% -$1.08M
CRBU icon
53
Caribou Biosciences
CRBU
$178M
$18.1M 0.39%
2,882,600
-290,000
-9% -$1.82M
ISEE
54
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$18M 0.39%
+838,407
New +$18M
PNT
55
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$17.7M 0.38%
2,432,400
-387,600
-14% -$2.83M
NSTG
56
DELISTED
NanoString Technologies, Inc.
NSTG
$16.4M 0.36%
2,057,200
+1,359,000
+195% +$10.8M
TWST icon
57
Twist Bioscience
TWST
$1.62B
$14.5M 0.32%
+611,000
New +$14.5M
BCAB icon
58
BioAtla
BCAB
$28.3M
$10.4M 0.23%
+1,260,000
New +$10.4M
CMPX icon
59
Compass Therapeutics
CMPX
$473M
$10.1M 0.22%
2,000,000
– –
SGMO icon
60
Sangamo Therapeutics
SGMO
$166M
$8.63M 0.19%
2,748,300
+387,500
+16% +$1.22M
ALPN
61
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$7.56M 0.16%
1,028,200
+29,600
+3% +$218K
KNTE
62
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$7.4M 0.16%
1,212,700
+89
+0% +$543
ANTX icon
63
AN2 Therapeutics
ANTX
$31.4M
$7.09M 0.15%
743,600
+970
+0.1% +$9.24K
IPSC icon
64
Century Therapeutics
IPSC
$42.5M
$6.69M 0.14%
1,303,600
– –
MSAC
65
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$5.24M 0.11%
520,000
– –
LENZ
66
LENZ Therapeutics
LENZ
$1.11B
$5.23M 0.11%
1,575,000
– –
ARYD
67
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$5.05M 0.11%
500,000
– –
PANA
68
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$5.03M 0.11%
500,000
– –
EPIX icon
69
ESSA Pharma
EPIX
$11.1M
$4.68M 0.1%
1,855,400
-604,600
-25% -$1.52M
OBIO icon
70
Orchestra BioMed
OBIO
$146M
$3.99M 0.09%
400,000
– –
SYRS
71
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.23M 0.07%
900,000
– –
CYT
72
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$2.96M 0.06%
1,795,800
-10,400
-0.6% -$17.2K
CMAX
73
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$2.76M 0.06%
755,329
– –
DNAB
74
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$2.01M 0.04%
200,000
– –
DNAD
75
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.01M 0.04%
200,000
– –
1 2
3
4 5